Merck & Co Inc (1MRKX): aksiya narxi va yangiliklar

Belgilar Belgilar	Narxi	Oʻzgartirishlar	Dinamika (%)	Trend	Avvalgi yopilish narxi	Ochish	Yuqori	Past	Hajmi	Bozor kapitali
SIXB Materials SIXB Materials	SIXB -0,71%	1 092,80	-7,77	-0,71%	—	1 100,57	1 098,94	1 103,80	1 084,24	—	—
SIXC Communications SIXC Communications	SIXC -0,07%	604,74	-0,41	-0,07%	—	605,15	605,15	606,69	602,76	—	—
SIXE Energy SIXE Energy	SIXE +1,64%	1 214,80	+19,61	+1,64%	—	1 195,19	1 204,71	1 221,69	1 204,71	—	—
SIXI Industrials SIXI Industrials	SIXI -0,88%	1 724,57	-15,34	-0,88%	—	1 739,91	1 734,50	1 734,50	1 710,67	—	—
SIXM Financials SIXM Financials	SIXM +0,14%	639,43	+0,87	+0,14%	—	638,56	640,21	645,32	638,69	—	—
SIXR Staples SIXR Staples	SIXR +0,91%	839,15	+7,58	+0,91%	—	831,57	840,48	844,16	834,54	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +1,06%	215,62	+2,26	+1,06%	—	213,36	213,36	215,79	212,77	—	—
SIXT Technology SIXT Technology	SIXT -1,69%	3 179,52	-54,66	-1,69%	—	3 234,18	3 171,86	3 195,36	3 145,46	—	—
SIXU Utilities SIXU Utilities	SIXU +0,13%	936,91	+1,26	+0,13%	—	935,65	937,31	941,44	933,16	—	—
SIXV Health care SIXV Health care	SIXV +0,24%	1 452,77	+3,51	+0,24%	—	1 449,26	1 454,77	1 462,65	1 447,95	—	—
SIXY Discretionary SIXY Discretionary	SIXY -0,72%	2 365,18	-17,27	-0,72%	—	2 382,45	2 371,19	2 380,45	2 362,86	—	—

1MRKX:BIT

Merck & Co Inc

95,49 €

+0,04%

(+0,040) 1K

27-apr, 15:47:51 (GMT+2) · EUR

Barcha belgilar

YBB

MAKS

	Belgi	Narxi	Oʻzgartirishlar	Dinamika (%)

1MRKX tikeri uchun statistika yaratilmoqda...

Bozor kapitali

271,76 mlrd

Oʻrtacha hajm

108,00

Hajmi

0,00

52 haftalik eng yuqori

110,20 €

52 haftalik eng past

65,40 €

Xodimlar soni

74 ming

Yangiliklar

Internetdagi manbalardan

Meyka

1 soat oldin

MRK Merck Earnings Preview April 30, 2026

StockStory

6 soat oldin

Merck (MRK) Q1 Earnings Report Preview: What To Look For

AOL.com

8 soat oldin

Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump

MarketBeat

23 soat oldin

Mitsubishi UFJ Trust & Banking Corp Sells 825,324 Shares of Merck & Co., Inc. $MRK

Profil

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia

Merck & Co Inc haqida

CEORobert M Davis

Xodimlar soni74 ming

Asos solingan1-yan, 1891

Bosh ofislar-

Sektor-

Veb-saytmerck.com

Barcha qiymatlar – USD	mar, 2025	iyn, 2025	sen, 2025	dek, 2025
Daromad	15,53 mlrd	15,81 mlrd	17,28 mlrd	16,40 mlrd
Sotilgan mahsulotning tannarxi	3,38 mlrd	3,39 mlrd	3,74 mlrd	4,30 mlrd
Daromad narxi	3,38 mlrd	3,39 mlrd	3,74 mlrd	4,30 mlrd
Tadqiqot va ishlanmalarga xarajatlar	3,52 mlrd	4,00 mlrd	4,00 mlrd	4,00 mlrd
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar	-	-	-	-
Tijoriy, umumiy va maʼmuriy xarajatlar	2,40 mlrd	2,50 mlrd	2,48 mlrd	2,73 mlrd
Operatsion xarajatlar	5,92 mlrd	6,49 mlrd	6,48 mlrd	6,73 mlrd
Jami operatsion xarajatlar	9,31 mlrd	9,88 mlrd	10,23 mlrd	11,02 mlrd
Operatsion daromad	6,22 mlrd	5,92 mlrd	7,05 mlrd	5,38 mlrd
Boshqa nooperatsion daromad	91,00 mln	69,00 mln	-	41,00 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar	5,90 mlrd	5,00 mlrd	6,74 mlrd	3,42 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno	6,02 mlrd	5,68 mlrd	6,76 mlrd	4,98 mlrd
Daromad soligʻi boʻyicha xarajat	818,00 mln	571,00 mln	958,00 mln	458,00 mln
Amaldagi soliq stavkasi	13,86%	11,42%	14,20%	13,39%
Boshqa operatsion xarajatlar	-	-	-	-
Sof foyda	5,08 mlrd	4,43 mlrd	5,78 mlrd	2,96 mlrd
Sof foyda marjasi	32,71%	28,01%	33,49%	18,07%
Har bir aksiya foydasi	2,22	2,13	2,58	2,04
Foizlar va investitsiyalardan olingan daromadlar	109,00 mln	69,00 mln	96,00 mln	69,00 mln
Foizlarni toʻlash xarajatlari	-313,00 mln	-305,00 mln	-327,00 mln	-411,00 mln
Foizlarni toʻlash boʻyicha sof xarajatlar	-204,00 mln	-236,00 mln	-231,00 mln	-342,00 mln
Amortizatsiya ajratmalari	-	-	-	-
EBITDA	7,28 mlrd	6,99 mlrd	8,15 mlrd	6,79 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar	-	-	-	-

AI kontentda xatolar boʻlishi mumkin. Batafsil

YordamFikr-mulohazaMaxfiylik Shartlar Majburiyatlardan voz kechish

Finance

Tahlil